1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends

Competitor Analysis: CD19-Targeted Therapeutics

  • October 2013
  • 34 pages
  • La Merie Publishing
Report ID: 1864717


Table of Contents

Search Inside

Renewed interest in CD19 as target for antibody and T-cell Therapeutics

The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, as well as follicular dendritic cells. CD19 serves as a diagnostic marker for B-cell malignancies. Virtually all cases of acute lymphoblastic leukemia (ALL) are CD19 positive. Years ago, naked antibodies have been generated against CD19, but clinical results were not sufficiently satisfactory. With the advent of new technologies to increase effector funtions of antibodies and to engineer cytotoxic T-lymphocytes to redirect them to CD19, this target has regained considerably interest in oncology.

The present Competitive Intelligence report about CD19-Targeted Therapeutics provides a competitor evaluation in the field of antibody- and T-cell-based therapeutics for the treatment of B-cell hematologic malignancies as of October 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of antibodies and T-cells targeting CD19 and with enhanced effector fucntion. In addition, the report lists company-specific R&D pipelines of CD19-Targeted Therapeutics. Competitor projects are listed in a tabular format providing information on:

-Drug Codes,
-Target / Mechanism of Action,
-Class of Compound,
-Product Category,
-R&D Stage and
-additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Soft Tissue Repair Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Soft Tissue Repair Soft tissue repair market consists of cell therapy-based products, tissue scaffolds, and soft tissue fixation devices and accessories. Cell therapy and tissue scaffold products ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • April 2017
  • by Currentpartnering

Summary The Global Gene Therapy Partnering Terms and Agreements 2010-2017 report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered ...

US Cell Surface Marker Testing Market 2021: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 1450
  • Industry report
  • June 2017
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.